{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:29:23Z","timestamp":1793212163893,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007380","name":"Fondation de l'Avenir pour la Recherche M\u00e9dicale Appliqu\u00e9e","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008765","name":"Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de Gastro-Ent\u00e9rologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cgh.2025.01.032","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:09:35Z","timestamp":1744628975000},"page":"2263-2271.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy"],"prefix":"10.1016","volume":"23","author":[{"given":"Charlotte","family":"Larson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob Benedict","family":"Seidelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille D.","family":"Ovesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Uzzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad D.","family":"Constant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Albenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"El-Hussuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Cohen-Mekelburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.R.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Steenholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.01.032_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-144-9-200605020-00010","article-title":"Patients\u2019 global ratings of their health care are not associated with the technical quality of their care","volume":"144","author":"Chang","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2025.01.032_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0021-9681(84)90044-4","article-title":"The effects of physician communications skills on patient satisfaction; recall, and adherence","volume":"37","author":"Bartlett","year":"1984","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2025.01.032_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13847","article-title":"Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis","volume":"45","author":"Mao","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.01.032_bib5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/ibd\/izz071","article-title":"Changes in vedolizumab utilization across US academic centers and community practice are associated with improved effectiveness and disease outcomes","volume":"25","author":"Koliani-Pace","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib6","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","article-title":"Global hospitalization trends for Crohn\u2019s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses","volume":"21","author":"Buie","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.01.032_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","article-title":"Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression","volume":"5","author":"Turner","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"26","key":"10.1016\/j.cgh.2025.01.032_bib8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2025.01.032_bib9","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"J\u00e4rnerot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.01.032_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.01.032_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2025.01.032_bib12","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.cgh.2021.05.038","article-title":"Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study","volume":"19","author":"Berinstein","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.01.032_bib13","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.14309\/ajg.0000000000002674","article-title":"Effectiveness of upadacitinib for patients with acute severe ulcerative colitis: a multi-center experience","volume":"119","author":"Berinstein","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.01.032_bib14","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ecco-jcc\/jjad036","article-title":"Tofacitinib for acute severe ulcerative colitis: a systematic review","volume":"17","author":"Steenholdt","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2025.01.032_bib15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14309\/ajg.0000000000002635","article-title":"Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): a randomized controlled trial","volume":"119","author":"Singh","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.01.032_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2018.07.009","article-title":"Tofacitinib induction therapy reduces symptoms within 3 days for patients with ulcerative colitis","volume":"17","author":"Hanauer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.01.032_bib17","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.cgh.2022.11.029","article-title":"Upadacitinib therapy reduces ulcerative colitis symptoms as early as day 1 of induction treatment","volume":"21","author":"Loftus","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.01.032_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.113.054940","article-title":"The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a Janus kinase inhibitor, in humans","volume":"42","author":"Dowty","year":"2014","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.cgh.2025.01.032_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2015.04.016","article-title":"Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis","volume":"149","author":"Brandse","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.01.032_bib20","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/MIB.0000000000000212","article-title":"Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study","volume":"20","author":"Dotan","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1208\/s12248-019-0378-y","article-title":"Development of in vitro\u2013in vivo correlation for upadacitinib extended-release tablet formulation","volume":"21","author":"Mohamed","year":"2019","journal-title":"AAPS J"},{"key":"10.1016\/j.cgh.2025.01.032_bib22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/codi.15702","article-title":"Perioperative safety of tofacitinib in surgical ulcerative colitis patients","volume":"23","author":"Lightner","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/apt.16463","article-title":"Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: a GETAID cohort","volume":"54","author":"Uzzan","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.01.032_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MPG.0000000000003616","article-title":"Tofacitinib salvage therapy for children hospitalized for corticosteroid- and biologic-refractory ulcerative colitis","volume":"75","author":"Constant","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2025.01.032_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2025.01.032_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2008.01.004","article-title":"Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis","volume":"134","author":"Kaplan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.01.032_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231189122","article-title":"Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program","volume":"16","author":"Rubin","year":"2023","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2025.01.032_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00384-019-03494-w","article-title":"Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors","volume":"35","author":"Schineis","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/codi.12328","article-title":"Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis","volume":"15","author":"Bartels","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/anae.16104","article-title":"Postoperative systemic inflammation after major abdominal surgery: patient-centred outcomes","volume":"78","author":"Bain","year":"2023","journal-title":"Anaesthesia"},{"key":"10.1016\/j.cgh.2025.01.032_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2022.03.057","article-title":"Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery","volume":"163","author":"Cohen","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.01.032_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2036.2009.04204.x","article-title":"Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis","volume":"31","author":"Yang","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.01.032_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.crohns.2011.08.014","article-title":"Infliximab and complications after colectomy in patients with ulcerative colitis","volume":"6","author":"Bregnbak","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2025.01.032_bib34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"Ferrante","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib35","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.2008.01942.x","article-title":"Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery","volume":"103","author":"Subramanian","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.01.032_bib36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.crohns.2014.07.007","article-title":"The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease","volume":"8","author":"Nguyen","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"9715","key":"10.1016\/j.cgh.2025.01.032_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2025.01.032_bib39","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/apt.15514","article-title":"Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme","volume":"50","author":"Sandborn","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.01.032_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2025.01.032_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/DCR.0000000000000982","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guideline for the prevention of venous thromboembolic disease in colorectal surgery","volume":"61","author":"Fleming","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2025.01.032_bib42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/codi.14853","article-title":"Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review","volume":"22","author":"McKechnie","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2025.01.032_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.surg.2021.03.058","article-title":"The reduced risk of septic shock\/sepsis with laparoscopic surgery among ulcerative colitis patients with preoperative chronic steroid use","volume":"170","author":"Lo","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2025.01.032_bib44","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00464-009-0819-2","article-title":"Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come","volume":"24","author":"Telem","year":"2010","journal-title":"Surg Endosc"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525002873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525002873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:39:42Z","timestamp":1777966782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1542356525002873"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.01.032","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AGA Institute","name":"copyright","label":"Copyright"}]}}